NeuroScientific Biopharmaceuticals Limited (ASX:NSB)

Market Cap	33.26M +505.2%
Revenue (ttm)	317.91K -85.6%
Net Income	-3.18M
EPS	-0.01
Shares Out	332.58M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	196,041
Average Volume	139,903
Open	0.1000
Previous Close	0.1000
Day's Range	0.0960 - 0.1000
52-Week Range	0.0340 - 0.2600
Beta	1.22
RSI	31.39
Earnings Date	Feb 25, 2026

About ASX:NSB

NeuroScientific Biopharmaceuticals Limited engages in the research and development of biomedical products targeting neurodegenerative conditions. Its lead product is the EmtinB drug for the treatment of optic nerve diseases, such as glaucoma. The company also develops StemSmart platform technology to treat inflammatory immune disorders. NeuroScientific Biopharmaceuticals Limited was incorporated in 2002 and is based in Perth, Australia.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2002
• Country: Australia
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: NSB